A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

Though Alzheimer's disease is often described as a buildup of proteins in the brain in the form of plaques and tangles, a new ...

Spending lower proportions of time in two deep sleep stages — including REM sleep — may be linked to volume changes in ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most ...

Roche Holding said it will initiate a late-stage trial for its Alzheimer's drug candidate trontinemab later this year after its mid-stage study showed positive results.

When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as a tool ...

Roche has reported preliminary results on its Alzheimer’s disease prospect trontinemab. | Roche has reported preliminary ...

左右滑动查看更多编者按：来自Alamar的NULISA技术在阿尔茨海默病（AD）研究领域迅速获得了全球科学家和产业界的广泛采用和关注。仅在2025年2月，就有四篇采用NULISA技术的研究成果同时发表于神经科学顶级期刊《Alzheimer's & ...